Hebrew University and Yissum Developing Novel Technology Platform for 3D Printing Personalized Medicine

Yissum, which is the Hebrew University of Jerusalem‘s technology transfer company and handles the patenting and commercialization of any inventions produced there, has had a hand in many unique 3D printing innovations, such as Nano Dimension’s conductive nano-inks and a process to generate hybrid machine elements. Last year, the company, which was founded in 1964 and has licensed over 900 technologies and registered over 10,000 patents covering 2,800 inventions, introduced a novel technology platform for 3D printing personalized food, and has now moved on to 3D printing personalized medicine.

The company, which is only the third of its kind, builds a bridge between academic research and its worldwide community of entrepreneurs, investors, and industry. It’s responsible for spinning more than 135 total companies. Yissum recently announced a novel technology platform for fabricating 3D printed drug capsules, and presented it today at the university’s 2nd annual 3D Printing and Beyond conference, which is sponsored by Yissum, the university, and the Jerusalem Development Authority.

Professor Shlomo Magdassi, head of the university’s 3D and Functional Printing Center and a member of the Center for Nanoscience and Nanotechnology and Institute of Chemistry, worked with Dr. Ofra Benny, a researcher at the university’s Institute for Drug Research, to develop the innovative drug 3D printing technology platform.

“Professor Magdassi and Dr. Benny’s research is an excellent example of the  kind of interdisciplinary transformational inventions that originate  from the Hebrew University,” said Dr. Yaron Daniely, CEO and President of Yissum. “This technology is bringing us closer to a future in which the medical field can offer personalized, patient-centered care.”

The technology is based on custom 3D printed hydrogels with delayed release characteristics, and allows for a complex design of drug delivery systems that is not currently available in the more traditional pharmaceutical manufacturing techniques.

Dr. Magdassi already has plenty of experience with 3D printed hydrogels and other unique 3D printable materials. 3D hydrogels are hydrophilic polymeric networks that are cross-linked by either chemical covalent bonds, physical interactions, or a combination. Because of these crosslinks between polymer chains and their hydrophilic nature, hydrogels can actually swell up to a hundred times, or even a thousand, of their dried mass without needing to be dissolved in water, and they are an ideal material for biomedical applications.

Yissum’s company mission is to take transformational technologies and innovations and convert them into commercial solutions that address the most urgent challenges in our world, in order to benefit society. I’d say this new 3D printing platform fits the bill – the approach makes it possible to 3D print customized medications out of hydrogel objects that can change shape, expand, and even activate on a delayed schedule.

The novel new 3D printing platform can not only achieve complex release profiles and structures of drugs, but it can also personalize prescription medicines, so doctors can more accurately tailor the dosage levels and exposure of medications for different patients. Thanks to 3D printing, medication may not have to be one-size-fits-all.

Professor Magdassi and Dr. Benny presented their work at the 3D Printing and Beyond conference today, which Professor Magdassi helps organize with Dr. Michael Layani. The conference brings together a range of researchers and industry leaders from around the world to discuss and learn more about the latest advances in defense-related technologies, electronics, and pharmaceuticals, in addition to 3D printed innovations like automotive parts and food.

Discuss this story and other 3D printing topics at 3DPrintBoard.com or share your thoughts in the Facebook comments below. 

New Study Discusses Unmet Clinical Needs Being Addressed by 3D Printing

3D printing continues to make a huge impact on the medical field – the evidence more than speaks for itself. But this important work is not done yet. A team of researchers based at the University of Utah recently published a review paper that, as Yong Lin Kong, PhD, an assistant professor in the university’s Department of Mechanical Engineering, told 3DPrint.com, “highlights the progress of 3D printing technologies in addressing unmet clinical needs.”

The paper, titled “Addressing Unmet Clinical Needs with 3D Printing Technologies” and published in Advanced Healthcare Materials, was written by Udayan Ghosh, Shen Ning with the Boston University School of Medicine, Yuzhu Wang, and Professor Kong.

A) 3D printed biomimetic bone environment for evaluating breast cancer bone metastasis; B) 3D printed network guide for regenerating damaged nerve plexuses; C) 3D printed titanium prosthetic for sternocostal reconstruction; D) An endothelialized myocardium by 3D printing endothelial cells encompassed within micro-fibrous hydrogel scaffolds; E) 3D printed personalized ocular prosthesis; F) Bionic ears; G) Hollow micrometer-scale microneedles; H) 3D printed pelvic implant.

The abstract reads, “Recent advances in 3D printing have enabled the creation of novel 3D constructs and devices with an unprecedented level of complexity, properties, and functionalities. In contrast to manufacturing techniques developed for mass production, 3D printing encompasses a broad class of fabrication technologies that can enable 1) the creation of highly customized and optimized 3D physical architectures from digital designs; 2) the synergistic integration of properties and functionalities of distinct classes of materials to create novel hybrid devices; and 3) a biocompatible fabrication approach that facilitates the creation and cointegration of biological constructs and systems. This progress report describes how these capabilities can potentially address a myriad of unmet clinical needs.”

The paper first looks at providing structural support for skeletal and tubular organs with 3D printed prosthetics in order to help people regain some of the functions they’ve lost, and then moves on to novel drug delivery strategies and organ-on-a-chip systems.

“Fourth, the developments of 3D-printed tissue and organ regeneration are explored,” the researchers explain in the paper. “Finally, the potential for seamless integration of engineered organs with active devices by leveraging the versatility of multimaterial 3D printing is envisioned.”

Society has been transformed by mass production, which allows parts to be manufactured at a far lower cost than hiring manual labor. However, that makes it difficult, and more expensive, to find customized products.

The researchers say in the paper, “Instead of optimizing for individual need and comfort, mass production manufacturing has compelled society to tolerate a finite set of prescribed designs determined by the overall market.”

Mass production doesn’t really address the complexity of the human body, and the majority of typical FDA-approved medical devices are not tailor-made to a patient’s specifications, which can many different issues that affect a person’s quality of life. But now, more and more physicians are investigating the use of 3D printing as it pertains to making cost-effective, customized devices.

“Indeed, 3D printing of biocompatible materials can create patient-specific prosthetics tailored to each patient’s unique anatomy and needs,” the researchers wrote.

3D printed prosthetics can help decrease discomfort, as they’re fitted to specific people, and at the same time are less expensive while also being more accessible. One specific, and very important, unmet clinical need that 3D printing can help with is creating functioning upper limb prostheses for children, so that they can grasp things in order to perform their basic daily activities. It’s hard to provide children with well-fitting prosthetics, as they grow so rapidly; that’s why a 3D printed version is a far better option.

Mock-up prototype of a microneedle array.

3D printed devices are also being used to help develop novel drug delivery strategies, from customized mouthguards and vaccines to microneedles and micro-rockets.

The researchers wrote, “Here, 3D printing enables the creation of unique architectures to allow painless delivery of therapeutic agents and tailored drug release profiles.”

Current strategies can be difficult when attempting to enable accurate drug delivery, but 3D printing has the potential to, as the paper puts it, “overcome these long- standing challenges.”

“3D printing introduced a potential opportunity for developing personalized, controlled, and precise drug delivery systems,” the researchers explained. “This technology achieves precise control of dosage in accordance with the size and dispensary mechanism of the design. Biocompatible material also allows for long-term implantation or retention while continuously dispensing controlled volumes with the potential to evolve into a highly efficient sensor-controlled drug dispensing system.”

3D printing is also being used now to address the unmet clinical need of the organ-on-a-chip platform, as it can summarize microenvironments in order to gain a more thorough understanding of cellular mechanics.

A) 3D printed in vitro human renal proximal tubules embedded within an extracellular matrix and housed in perfusable tissue chips. B) Customizable 3D printed nervous system-on-a-chip. The circular pattern of 3D printed silicone tri-microchannels designed for axonal guidance (L). A microscopy image shows three parallel microchannels of neurons and axons (green) in a chamber (R).

“Tissue/lab-on-a-chip, synonymous to biomedical application of microfluidics, is an advantageous and cost-effective way to investigate basic research questions. Analyzing fluids at the micrometer scale using microfluidic device holds immense promises for biological research,” the researchers said in the paper.

Ongoing research into tissues-on-a-chip is working to develop tissue chips that can act as accurate models for a specific organ’s function and structure, and 3D printing is the perfect technology for the job. Research also continues for the use of 3D bioprinting in tissue regeneration, as it can be used to create biocompatible constructs and 3D printed scaffolds to help regrow damaged tissues and organs, such as ears.

The researchers explained, “Bone tissue–engineered 3D constructs are more advantageous than 2D cell cultures due to the structure and mechanical composition 3D printing can produce to mimic the bone tissue microenvironment.”

Liver on a chip

Finally, the team touched on multimaterial 3D printing, which can help speed up “the creation of bioelectronic constructs to impart active functionalities to an otherwise passive construct.”

“The incorporation of electronics into biomedical devices and biological scaffolds is a foundational concept, which when applied, can mimic and even augment the complex functionalities of biological systems,” the researchers continued.

By integrating medical instruments with electronics, we can develop sophisticated new bioelectronic devices that are actually able to process feedback from the human body. The level of integration demonstrated by conventional fabrication techniques is rather limited, but using 3D printing to achieve these devices opens up far more possibilities – even, as the researchers explain, “the ability to mimic or surpass complex functionalities intrinsic to biological organs.”

“To date, demonstrations of a seamless bioelectronics 3D printing have been limited to passive electronic components, such as conductive traces and capacitors,” the researchers explained. “The integration of active electronic devices could impart an otherwise passive construct with optical, sensing, and computational capabilities.

“We anticipate that similar approaches can develop 3D printing strategies of various classes of active electronics. Nevertheless, the biocompatibility of such approach must be critically assessed to ascertain a full translational result from the bench to the bedside.

There’s a lot to think about here, but one thing is certain – the research into how we can address a myriad of unmet clinical needs with 3D printing should continue.

Discuss this story and other 3D printing topics at 3DPrintBoard.com or share your thoughts in the Facebook comments below.